Longitudinal monitoring of tumor response with MT218-MRMI demonstrated a significant reduction in EDB-FN following treatment with RGD-ELNP/miR-200c, indicating tumor ECM remodeling and reduced total fibronectin expression, consistent with mRNA level decreases in extracted tumors. The gene discussed is FN1; the disease is neoplasm.